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Abstract
Poor HIV care retention impedes optimal treatment outcomes in persons living with HIV. Women trying to become preg-
nant may be motivated by periconception horizontal and vertical transmission concerns and thus more likely to attend HIV 
care visits than women not trying to conceive. We estimated the effect of fertility intentions on HIV care attendance over 
12 months among non-pregnant, HIV-positive women aged 18–35 years who were on or initiating antiretroviral therapy 
in Johannesburg, South Africa. The percentage of women attending an HIV care visit decreased from 93.4% in the first 
quarter to 82.8% in the fourth quarter. Fertility intentions were not strongly associated with care attendance in this cohort 
of reproductive-aged women; however, attendance declined over time irrespective of childbearing plans. These findings 
suggest a need for reinforced efforts to support care engagement and risk reduction, including safer conception practices for 
women wishing to conceive.
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Introduction
Sustained engagement in HIV care is required for optimal 
clinical and prevention outcomes. Although advances in 
global antiretroviral therapy (ART) programs have expanded 
treatment availability for persons living with HIV [1], poor 
attendance at clinical care visits, high loss to follow-up, and 
inadequate ART use continue to impede efforts to optimize 
treatment and prevention worldwide [2, 3].
One factor that that may influence engagement in care 
is decision-making around childbearing. Women who are 
trying to conceive have different clinical needs than women 
not trying to become pregnant [4], potentially precipitating 
differences in the frequency with which women attend HIV 
clinical care visits. Women who are conscious of their preg-
nancy plans may be motivated to adopt healthier behaviors 
in the preconception period [5], including improved ART 
adherence to maintain their own physical health. Concerns 
about horizontal transmission [6, 7] or mother-to-child trans-
mission [8] may also motivate women who are planning to 
conceive to have a more consistent relationship with HIV 
care, particularly among those who discussed their fertility 
intentions with a provider or those who were counseled on 
reducing transmission risk during an earlier pregnancy.
Results of this study were presented in part at the 2018 
International AIDS Conference (AIDS 2018). Amsterdam, The 
Netherlands: July 23–27, 2018.
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In South Africa and other sub-Saharan African settings, 
research around ART adherence and periconception HIV 
care retention is largely framed around prevention of mother-
to-child transmission (PMTCT) [9–11], and relatively few 
studies have explicitly evaluated HIV treatment outcomes 
in women outside of the pregnancy and postpartum peri-
ods [10, 12–14]. In particular, few studies have explicitly 
assessed the relationship between fertility intentions and 
retention in HIV care. Here, we estimated the effect o f 
fertility intentions on attendance at HIV clinical care vis-
its among HIV-positive women on ART in Johannesburg, 
South Africa.
Methods
Study Setting, Population and Procedures
We performed a secondary analysis of longitudinal data 
from a prospective cohort study conducted in Johannesburg 
between 2009 and 2011. This original study was designed 
to estimate the 12-month incidence of pregnancy in HIV-
positive women on ART. Full descriptions of study proce-
dures and eligibility criteria have been published elsewhere 
[15–19]. Briefly, non-pregnant, sexually active women 
between the ages of 18 and 35 years receiving ART care at 
one of four public community or primary health clinics were 
eligible for participation if they had not been pregnant in the 
last 3 months; were not breastfeeding; had not had a previous 
tubal ligation, hysterectomy, or bi-lateral oophorectomy; and 
had not been diagnosed as permanently infertile. Pregnancy 
was assessed using a urine-based pregnancy test (One Step 
hCG Urine Pregnancy Test, Atlas Link Technology, Beijing) 
at enrollment. After providing written informed consent, eli-
gible women completed an interviewer-administered ques-
tionnaire. Questionnaires assessed demographic character-
istics, fertility history and intentions, contraceptive use, and 
sexual risk behaviors. ART regimen information, CD4 cell 
count and viral load data were abstracted through medical 
record review, pharmacy, and laboratory records.
Study follow-up visits coincided with routine HIV care 
visits, every 1–3 months based on clinic protocol and ART 
supply. During follow-up visits, women were assessed for 
pregnancy (via urine-based pregnancy test) and updated 
HIV-associated clinical characteristics were recorded (i.e., 
CD4 count and HIV viral load). Current contraceptive use 
and fertility intentions were assessed at each visit using a 
short questionnaire.
Fertility intentions were measured at enrollment using 
three questions that asked about current and future child-
bearing plans. Women were first asked if they were trying 
to conceive at time of interview (yes/no). Those who said no 
were then asked if they were planning to conceive in the 
next 
12 months (yes/no/uncertain). Those who said no or were 
uncertain were then asked if they were planning to conceive 
someday in the future (yes/no/uncertain).
During follow-up, women were only asked if they were 
trying to conceive at the time of each HIV clinical care visit 
(yes/no).
Exposure and Outcome Definitions
We created three dichotomous exposure variables for fer-
tility intentions: two time-fixed variables based on assess-
ments at enrollment and one time-varying variable based 
on assessments across follow-up. We first created a time-of-
enrollment variable reflecting short-term plans for childbear-
ing. Those reporting at enrollment that they were currently 
trying to conceive, as well as those who answered “yes” or 
“uncertain” to the question about plans to conceive in the 
next 12 months, were classified as having short-term plans 
for childbearing. Those who answered “no” at enrollment to 
questions about current or 12-month conception plans were 
classified as not having short-term plans for childbearing. 
We constructed a second dichotomous time-of-enrollment 
variable to reflect any plans for childbearing, classifying 
those answering “yes” or “uncertain” to any of the three 
questions about conception intentions (at time of interview, 
in the next 12 months, or someday in the future) as having 
plans for childbearing; those answering “no” to all three 
fertility intentions questions were classified as not having 
plans for childbearing. Third, we created a time-varying 
dichotomous variable reflecting current fertility intentions, 
basing classifications on the single yes/no question assessing 
current conception attempts at the time of interview in each 
quarter. In sensitivity analyses, women with uncertain fertil-
ity intentions (time-fixed variables only) were re-classified 
as having no plans to conceive.
To estimate the effect of each categorization of fertil-
ity intentions on attendance at HIV clinical care visits, we 
constructed an analytic cohort in which each woman was 
followed from study enrollment through the completion of 
12 months of follow-up or until date of censoring if she 
became pregnant or died. We partitioned the 12-month fol-
low-up period into 3-month intervals (quarters). Attendance 
at HIV clinical care visits was assessed dichotomously in 
each quarter: a woman was classified as having attended a 
visit in a given interval if she attended one or more routine 
HIV clinical care visits in that interval.
Statistical Analysis
Demographic and clinical characteristics of women at 
enrollment were described using proportions for categori-
cal variables and medians for continuous variables. Chi 
square (χ2) tests were used to compare the differences in 
proportions between groups for categorical variables, and 
Wilcoxon signed-rank sum tests were used for continuous 
data (α = 0.05).
We used an extension of the modified Poisson regres-
sion model [20, 21] to estimate risk ratios for the associa-
tion between care attendance and each exposure variable. 
To estimate risk differences, we fit Poisson models with an 
identity link and a robust variance estimator under a gen-
eralized estimating equations (GEE) framework [22]. For 
each comparison, an exchangeable correlation structure was 
specified to account for within-subject correlation between 
outcomes (multiple intervals of potential care attendance 
per woman) [23]. To ensure temporality in our analysis of 
time-varying fertility intentions—that is, to ensure that the 
fertility intentions measure preceded a given care attendance 
measure—we included a time lag. More specifically, we 
assessed attendance quarterly among women who reported 
they were either trying or not trying to conceive at their visit 
in the previous quarter.
To determine whether the relationship between fertil-
ity intentions (assessed at enrollment) and care attendance 
varied by treatment experience, we considered potential 
effect measure modification (EMM) by ART duration and 
CD4 count {using most recently collected CD4 [median 
time since CD4 testing 3.2 months (IQR 2, 5)]} assessed 
at enrollment. To assess EMM by ART duration, we com-
pared women who had initiated or reinitiated ART within 
3 months of study enrollment (recent initiators) with those 
who had been on ART for more than 3 months (ART expe-
rienced). CD4 count was categorized as < 200 or ≥ 200 cells/
ml. To formally test for EMM, we included an interaction
term between the time-fixed dichotomized exposure meas-
ures of fertility intentions and each of the proposed modi-
fiers. We considered both the magnitude and precision of
stratum-specific estimates when making a final determina-
tion of EMM.
All analyses were conducted using SAS statistical soft-
ware (SAS, version 9.4, Cary, NC).
Weights
To address potential selection bias in this analysis we con-
structed two sets of weights. First, to account for the pos-
sibility of informative censoring (whereby censoring due 
to pregnancy or death was associated with the exposure/
outcome) we calculated time-varying inverse probability of 
censoring weights. Pooled logistic regression models were 
used to estimate censoring weights for each exposure, and 
weights were stabilized and multiplied over time [24]. Sec-
ond, in our analysis of time-varying fertility intentions, we 
applied inverse probability of selection weights to account 
for missing exposure information due to a missed visit in the 
prior interval [25]. The probability of having an observed 
exposure measure was modeled as a function of age, CD4 
count and having prior children, and weights were stabilized 
by the marginal probability of having an exposure measure 
that was observed.
To account for confounding, we used stabilized inverse 
probability of exposure weights (IPW) to calculate weighted 
risk ratios and risk differences [26]. A minimally sufficient 
set of covariates for attendance and each categorization of 
fertility intentions was identified using a causal directed 
acyclic graph [27]. Covariates in the minimally sufficient 
set were measured at enrollment and included age, marital 
status, ART duration, partner fertility intentions and having 
prior children. Our use of censoring weights and selection 
weights informed our decision to use IPW instead of other 
adjustment methods. For each exposure, IPW were stabi-
lized by the marginal probability of having that exposure 
and weights were truncated at the 5th and 95th percentiles 
to further improve stability.
Results
We enrolled 850 women between August 2009 and Janu-
ary 2010 and followed them for up to 12 months. Over the 
12-month follow-up period, 149 women (17.5%) became
pregnant and contributed a median of 6.2 months (IQR 4,
9) of follow-up before they were censored. No deaths were
reported during follow-up. Twenty-eight (3.8%) women
did not return to care after their initial study visit. Women
were a median of 30.4 years old at enrollment (IQR 27, 33)
and fewer than half were married or co-habiting (44.5%)
(Table 1). Most (89.4%) had previously been pregnant.
Median time since HIV diagnosis was 24.0 months (IQR 12,
48), and median time since ART initiation was 13.2 months
(IQR 5, 24).
Approximately half (46.6%) of women reported having 
short-term plans for childbearing (either trying to become 
pregnant at time of interview or sometime within the next 
12 months) at enrollment, including 12.4% who were try-
ing to conceive at enrollment. Compared to women without 
plans to conceive in the short term, women with short-term 
childbearing plans were more likely to be married/co-habit-
ing (50.3% vs. 39.4%), less likely to have been previously 
pregnant (82.6% vs. 95.3%), and less likely to be taking hor-
monal contraception (18.4% vs. 33.3%). The proportion of 
women who had achieved viral suppression (< 50 copies/ml) 
was similar in both groups.
The overall probability of attending an HIV clinical care 
visit decreased from 93.4% in the first quarter to 82.8% in 
the fourth quarter. When we compared women with short-
term plans for childbearing at enrollment to those without 
short-term plans, we detected no difference in attendance 
in unweighted and weighted models (Table 2). When we 
Table 1  Characteristics at enrollment of 850 women with HIV taking ART in Johannesburg, 2009–2011
IQR interquartile range, No number, ART antiretroviral therapy
a Chi square (χ2) tests were used to compare the differences in proportions between groups for categorical variables, and Wilcoxon signed-rank 
sum tests were used for continuous data (α = 0.05)
b n = 834
Overall N = 850 (100.0%) Short-term childbearing plans 
N = 396 (46.6%)
Long-term or no childbearing 
plans N = 454 (53.4%)
p  valuea
Median IQR Median IQR Median IQR
Age (years) 30.4 27–33 30.0 28–33 31.0 28–34 0.55
No. living children 1.0 1–2 1.0 0–1 2.0 1–2 < 0.01
Months since HIV diagnosis 24.0 12–48 24.0 12–48 24.5 12–48 0.11
CD4 count, cells/ml 312.0 178–462 270.5 169–425 345.5 196–492 < 0.01
Months on ART 13.2 5–24 10.8 3–22 14.0 7–27 < 0.01
n % n % n %
Married/cohabitating 378 44.5 199 50.3 179 39.4 < 0.01
Ever pregnant 760 89.4 327 82.6 433 95.3 < 0.01
Trying to conceive, currently 105 12.4 105 26.5 0 0
Taking hormonal contraception 224 26.4 73 18.4 151 33.3 < 0.01
Pregnant at HIV diagnosis 271 31.9 84 21.2 187 41.2 < 0.01
Viral load < 50 copies/mlb 618 74.1 277 71.2 341 76.6 0.07
Table 2  Unweighted and 
Weighted Risk Ratios (RRs), 
Risk Differences (RDs) and 
95% CIs for the effect of 
fertility intentions on quarterly 
attendance at HIV clinical 
care visits among 850 women 
with HIV taking ART in 
Johannesburg, 2009–2011
RR risk ratio, RD risk difference, CI confidence interval, ART Antiretroviral therapy
a Weighted effect estimates account for censoring (mean = 1.01; range 0.37–2.26) and confounding by age 
(≤ 30, > 30 years), marital status (married or co-habitating/not married or co-habitating), time on ART (ini-
tiated ART ≤ 3 vs. > 3 months before enrollment), partner fertility intentions (no partner, partner does not 
desire a/another child, partner unsure, partner desires a/another child) and any prior living children (yes/no) 
(mean = 0.99; range 0.49–4.18)
b Weighted effect estimates account for censoring (mean = 1.00; range 0.40–1.73) and confounding by age 
(≤ 30, > 30 years), marital status (married or co-habitating/not married or co-habitating), time on ART (ini-
tiated ART ≤ 3 vs. > 3 months before enrollment), partner fertility intentions (no partner, partner does not 
desire a/another child, partner unsure, partner desires a/another child) and any prior living children (yes/no) 
(mean = 0.97; range 0.34–3.19)
c Weighted effect estimates account for censoring (mean = 1.00; range 0.42–1.86), selection (mean = 1.04; 
range 0.54–1.65), and confounding by age (≤ 30, > 30 years), marital status (married or co-habitating/not 
married or co-habitating), time on ART (initiated ART ≤ 3 vs. > 3 months before enrollment), partner fertil-
ity intentions (no partner, partner does not desire a/another child, partner unsure, partner desires a/another 
child) and any prior living children (yes/no) (mean = 0.97; range 0.26–1.93)
Unweighted Weighted
RR (95% CI) RD (95% CI) RR (95% CI) RD (95% CI)
Short-term childbearing  plansa
 Yes 0.98 (0.96, 1.00) − 0.02 (− 0.05, 0.01) 0.99 (0.96, 1.02) − 0.01 (− 0.05, 0.02)
 No Ref Ref Ref Ref
Any childbearing  plansb
 Yes 1.00 (0.97, 1.03) 0.00 (− 0.04, 0.03) 1.01 (0.96, 1.06) 0.01 (− 0.05, 0.06)
 No Ref Ref Ref Ref
Currently trying to conceive (time-varying)c
 Yes 1.01 (0.98, 1.04) 0.01 (− 0.02, 0.04) 1.03 (1.00, 1.06) 0.03 (0.00, 0.05)
 No Ref Ref Ref Ref
compared women with any plans for childbearing at enroll-
ment to those reporting no such plans, care attendance was 
also similar between groups. Results did not change substan-
tively in sensitivity analyses where women with uncertain 
fertility intentions were re-classified as having no plans to 
conceive (Online Appendix 1). In our assessment of time-
varying fertility intentions, women who were trying to 
conceive at a particular visit were slightly more likely to 
attend an HIV clinical care visit in the following quarter 
than women who were not trying to conceive at that time 
[RR 1.03 (95% CI 1.00, 1.06); RD 0.03 (95% CI 0.00, 0.05)]. 
However, attendance was > 80.0% in the fourth quarter for 
both groups. There did not appear to be modification by 
ART duration or CD4 count (Online Appendix 2).
Discussion
In this study of South African women on ART, we expected 
that women with immediate or short-term plans to conceive 
would exhibit greater care engagement than those with less 
proximal plans to become pregnant. Instead, we observed 
comparable engagement overall between these groups over 
the subsequent year. Care attendance in the subsequent quar-
ter was marginally greater among women currently trying 
to conceive at a given visit compared to women who were 
not trying to conceive, but the estimated incremental differ-
ence in retention may not be programmatically meaningful 
in this population.
Maternal concerns around mother-to-child transmission 
are thought to motivate care attendance during pregnancy in 
some HIV-positive women [8, 13, 28–30], and we expected 
that women in our study would demonstrate similar health-
seeking behaviors in the periconception period. Addition-
ally, concerns about horizontal transmission to HIV-unin-
fected partners during attempts to become pregnant could 
prompt better attendance at HIV clinical care visits among 
women trying to conceive [6, 7]. However, we found little 
difference in care attendance among women with and with-
out plans for childbearing (short-term or any), an indication 
that fertility intentions may not markedly impact care attend-
ance in this population.
Consistent with other short-term estimates of retention in 
South Africa [31], overall HIV care attendance in our study 
population remained > 80% at the end of 12 months. As 
follow-up began at study entry and not at a more clinically 
meaningful milestone (e.g., HIV diagnosis, linkage to care, 
ART initiation) [32], our population may have been biased 
towards women already enrolled and retained into long-
term HIV care. As such, the relatively high proportion of 
attendance may have attenuated the magnitude of our effect 
estimates [33], thus affecting this study’s ability to iden-
tify differences in care attendance by different childbearing 
plans. In subgroup analysis among women who had recently 
initiated ART, however, estimates were largely similar to 
results in the full cohort, although precision was limited.
A strength of this study was our use of prospectively 
collected and time-updated measures of current fertility 
intentions that preceded pregnancy assessment, which may 
have reduced potential exposure misclassification [34, 35]. 
Though dynamic, fertility intentions are often not assessed 
routinely within the context of HIV clinical care [36, 37], 
and so we also considered baseline (time-fixed) fertility 
intentions measures pertaining to less proximal time hori-
zons that enabled us to assess a range of childbearing sce-
narios and their respective effects on HIV care attendance. 
Furthermore, although more multidimensional measures of 
fertility intentions may provide additional insights into wom-
en’s family planning needs [38, 39], the measures of fertility 
intentions included in this study were highly predictive of 
pregnancy incidence among women with stated intentions 
to conceive in this study population [15, 16].
This analysis has some limitations. First, women in this 
study who missed one or more routine HIV care visits may 
have engaged in care elsewhere without our knowledge [40]. 
However, attendance was relatively high among all partici-
pants, minimizing the likelihood that any misclassification 
of missed visits would have biased the overall interpretation 
of our results [33]. Second, our assessment of attendance 
using quarterly visits may have disregarded circumstances 
in which women were advised to return to care more than 
3 months after a given visit. Because date of next clinic 
visit was not routinely collected during the study period, a 
“days late” or “missed appointments” definition of care dis-
engagement was not possible [41]. Third, questions regard-
ing exposure to safer conception services were administered 
only at the end of follow-up [17], and thus we were unable to 
ascertain whether or not safer conception knowledge modi-
fied the relationship between fertility intentions and care 
attendance in this analysis. Fourth, data included in this 
study were collected prior to South African national service 
delivery guidelines around earlier thresholds for treatment 
initiation, and thus the generalizability of our results to the 
modern era of universal treatment is uncertain. Finally, we 
cannot discount the possibility of unmeasured confounding, 
although all confounders identified by our directed acyclic 
graph were included in final models.
While retention remained relatively high in this popula-
tion, by just 12 months attendance was predicted to have 
decreased to approximately 80% irrespective of childbear-
ing plans. To the extent that routine HIV care visits pre-
sent opportunities to offer contraceptive counseling and 
pregnancy testing, missed visits may prevent women in this 
population from fully meeting their family planning needs. 
We have previously reported both a high probability of 
unmet need for contraception [19] and a high incidence of 
unplanned pregnancy in this cohort [16]. Though an assess-
ment of unmet need for contraception and its relationship 
with care attendance was beyond the scope of this analysis, 
only 26% of women reported using a method of hormonal 
contraception to prevent pregnancy at enrollment. Contra-
ceptive use among those without more immediate plans for 
pregnancy was notably only 33%.
Our findings reaffirm the need for expanded efforts to 
help women to remain engaged in HIV care, including dur-
ing the periconception period. Routine screening of fertility 
intentions, accompanied by rapid referrals for safer con-
ception, may offer the potential to improve periconception 
care engagement and HIV transmission prevention in South 
Africa. Safer conception services, which support the repro-
ductive goals of HIV-positive women and their partners, can 
reduce the risks of HIV transmission through pregnancy and 
pregnancy attempts, identify and treat sexually transmitted 
infections, and potentially engage sexual partners to opti-
mize care delivery [42]. For women who are already attend-
ing routine HIV care visits in the periconception period, 
safer conception counseling can promote ART adherence 
and encourage limiting pregnancy attempts until viral sup-
pression can be achieved and maintained. Viral suppres-
sion prevalence was just 71% among women with short-
term plans to conceive in this study, highlighting the need 
for reinforced efforts to support care engagement and risk 
reduction strategies during periconception. While safer con-
ception has been found to be both acceptable and feasible 
in South Africa [43], services remain largely unavailable 
outside of research settings [4]. Our study contributes to a 
growing body of evidence that supports routine implementa-
tion of safer conception services during periconception to 
increase care engagement and optimize HIV prevention in 
this population.
In summary, our findings suggest that women with plans 
for pregnancy have comparable engagement in care to other 
women. However, we report a non-trivial decline in attend-
ance over a 12-month period among both women with and 
without plans for childbearing, as well as a suboptimal 
viral suppression prevalence among women with plans to 
conceive. Efforts to ensure sustained care engagement and 
treatment adherence after ART initiation, particularly during 
periconception, remain critical.
Acknowledgements We offer our gratitude to the participants, clinic 
staff and study team for their contributions and support of the study. 
KR, SS, KP, BP, BC and AP contributed to the conception and the 
design of the analysis. VB and HR were involved in data collection, 
study management and the design of the original parent study. All 
authors contributed to the drafting and editing of the manuscript, inter-
pretation of the data, approval of the final version and are accountable 
for all aspects of the work presented here.
Funding This study received funding from the United States Centers 
for Disease Control and Prevention (CDC) public health dissertation 
grant 1R36PS001584-01. The research was conducted in clinics sup-
ported by PEPFAR (President’s Emergency Plan For AIDS Relief) 
and the United States Agency for International Development. KR was 
supported by National Institutes of Health (2T32AI102623-06) and 
an award through the Society of Family Planning Research Fund; BC 
was supported by the National Institutes of Health (5K24AI12079-03). 
The funders had no role in study design, data collection and analysis, 
decision to publish, or preparation of the manuscript.
Compliance with Ethical Standards 
Conflict of interest The authors declare that they have no conflict of 
interest.
Ethical Approval All procedures performed in studies involving human 
participants were in accordance with the ethical standards of the insti-
tutional and/or national research committee and with the 1964 Helsinki 
declaration and its later amendments or comparable ethical standards.
Informed Consent Informed consent was obtained from all individual 
participants included in the study.
References
1. World Health Organization WHO. Guideline on when to start
antiretroviral therapy and on pre-exposure prophylaxis for HIV.
Geneva, Switzerland: 2015. http://apps.who.int/iris/bitst ream/
handl e/10665 /18627 5/97892 41509 565_eng.pdf;jsess ionid 
=B4E6D 43F09 BA3E2 23B53 0E069 E1A8C 89?seque nce=1.
Accessed 1 Dec 2018.
2. Fox MP, Rosen S. Retention of adult patients on antiretroviral
therapy in low- and middle-income countries: systematic review
and meta-analysis 2008–2013. J Acquir Immune Defic Syndr.
2015;69(1):98–108.
3. Levi J, Raymond A, Pozniak A, Vernazza P, Kohler P, Hill A.
Can the UNAIDS 90-90-90 target be achieved? A systematic
analysis of national HIV treatment cascades. BMJ Glob Health.
2016;1(2):e000010.
4. Davies NE, Matthews LT, Crankshaw TL, Cooper D, Schwartz
SR. Supporting HIV prevention and reproductive goals in an
HIV-endemic setting: taking safer conception services from pol-
icy to practice in South Africa. J Int AIDS Soc. 2017;20(Suppl
1):21271.
5. Stephenson J, Patel D, Barrett G, et al. How do women prepare
for pregnancy? Preconception experiences of women attending
antenatal services and views of health professionals. PLoS ONE. 
2014;9(7):e103085.
6. Schwartz SR, Bassett J, Holmes CB, et  al. Client uptake of
safer conception strategies: implementation outcomes from the
Sakh’umndeni Safer Conception Clinic in South Africa. J Int
AIDS Soc. 2017;20(Suppl 1):21291.
7. Matthews LT, Moore L, Milford C, et al. “If I don’t use a con-
dom… I would be stressed in my heart that I’ve done something
wrong”: routine prevention messages preclude safer conception
counseling for HIV-infected men and women in South Africa.
AIDS Behav. 2015;19(9):1666–75.
8. Clouse K, Schwartz S, Van Rie A, Bassett J, Yende N, Pettifor A. 
“What They Wanted Was to Give Birth; Nothing Else”: barriers to 
retention in option B plus HIV care among postpartum women in
South Africa. J Acquir Immune Defic Syndr. 2014;67(1):E12–8.
9. Nachega JB, Uthman OA, Anderson J, et  al. Adherence to
antiretroviral therapy during and after pregnancy in low-income,
middle-income, and high-income countries: a systematic review 
and meta-analysis. AIDS. 2012;26(16):2039–52.
 10. Haas AD, Msukwa MT, Egger M, et al. Adherence to antiretrovi-
ral therapy during and after pregnancy: cohort study on women
receiving care in Malawi’s option B+ program. Clin Infect Dis.
2016;63(9):1227–35.
 11. Haas AD, Tenthani L, Msukwa MT, et al. Retention in care during 
the first 3 years of antiretroviral therapy for women in Malawi’s
option B+ programme: an observational cohort study. Lancet HIV. 
2016;3(4):e175–82.
 12. Brittain K, Remien RH, Mellins CA, et al. Determinants of subop-
timal adherence and elevated HIV viral load in pregnant women
already on antiretroviral therapy when entering antenatal care in
Cape Town, South Africa. AIDS Care. 2018;30:1–7.
 13. Henegar CE, Westreich DJ, Maskew M, Miller WC, Brookhart
MA, Van Rie A. Effect of pregnancy and the postpartum period
on adherence to antiretroviral therapy among HIV-infected
women established on treatment. J Acquir Immune Defic Syndr.
2015;68(4):477–80.
 14. Matthews LT, Ribaudo HB, Kaida A, et al. HIV-Infected Ugandan 
women on antiretroviral therapy maintain HIV-1 RNA suppres-
sion across periconception, ptegnancy, and postpartum periods. J 
Acquir Immune Defic Syndr. 2016;71(4):399–406.
 15. Schwartz SR, Mehta SH, Taha TE, Rees HV, Venter F, Black V.
High pregnancy intentions and missed opportunities for patient-
provider communication about fertility in a South African cohort 
of HIV-positive women on antiretroviral therapy. AIDS Behav.
2012;16(1):69–78.
 16. Schwartz SR, Rees H, Mehta S, Venter WD, Taha TE, Black V.
High incidence of unplanned pregnancy after antiretroviral ther-
apy initiation: findings from a prospective cohort study in South
Africa. PLoS ONE. 2012;7(4):e36039.
 17. Steiner RJ, Black V, Rees H, Schwartz SR. Low receipt and uptake 
of safer conception messages in routine HIV care: findings from
a prospective cohort of women living with HIV in South Africa.
J Acquir Immune Defic Syndr. 2016;72:105–13.
 18. Schwartz S, Taha TE, Venter WD, Mehta S, Rees H, Black V.
Efavirenz conceptions and regimen management in a prospec-
tive cohort of women on antiretroviral therapy. Infect Dis Obstet
Gynecol. 2012;2012:723096.
 19. Rucinski KB, Powers KA, Schwartz SR, et  al. Longitudinal
patterns of unmet need for contraception among women living
with HIV on antiretroviral therapy in South Africa. PLoS ONE.
2018;13(12):e0209114.
 20. Zou G. A modified poisson regression approach to prospective
studies with binary data. Am J Epidemiol. 2004;159(7):702–6.
 21. Zou GY, Donner A. Extension of the modified poisson regres-
sion model to prospective studies with correlated binary data. Stat 
Methods Med Res. 2013;22(6):661–70.
 22. Pedroza C, Thanh Truong VT. Performance of models for esti-
mating absolute risk difference in multicenter trials with binary
outcome. BMC Med Res Methodol. 2016;16(1):113.
 23. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized 
linear models. Biometrika. 1986;73(1):13–22.
 24. Howe CJ, Cole SR, Lau B, Napravnik S, Eron JJ Jr. Selection
bias due to loss to follow up in cohort studies. Epidemiology.
2016;27(1):91–7.
 25. Bengtson AM, Pence BW, Gaynes BN, et al. Improving depression
among HIV-infected adults: transporting the effect of a depression 
treatment intervention to routine care. J Acquir Immune Defic
Syndr. 2016;73(4):482–8.
 26. Cole SR, Hernan MA. Constructing inverse probability
weights for marginal structural models. Am J Epidemiol.
2008;168(6):656–64.
 27. Greenland S, Pearl J, Robins JM. Causal diagrams for epidemio-
logic research. Epidemiology. 1999;10:37–48.
 28. Clouse K, Pettifor A, Shearer K, et al. Loss to follow-up before
and after delivery among women testing HIV positive during
pregnancy in Johannesburg, South Africa. Trop Med Int Health.
2013;18(4):451–60.
 29. Ngarina M, Popenoe R, Kilewo C, Biberfeld G, Ekstrom AM.
Reasons for poor adherence to antiretroviral therapy postnatally
in HIV-1 infected women treated for their own health: experi-
ences from the Mitra Plus study in Tanzania. BMC Public Health. 
2013;13:450.
 30. Hodgson I, Plummer ML, Konopka SN, et al. A systematic review 
of individual and contextual factors affecting ART initiation,
adherence, and retention for HIV-infected pregnant and postpar-
tum women. PLoS ONE. 2014;9(11):e111421.
 31. Cornell M, Grimsrud A, Fairall L, Fox MP, van Cutsem G, Giddy 
J, et al. Temporal changes in programme outcomes among adult
patients initiating antiretroviral therapy across South Africa,
2002–2007. AIDS (London, England). 2010;24(14):2263.
 32. Cole SR, Hudgens MG. Survival analysis in infectious disease
research: describing events in time. AIDS. 2010;24(16):2423–31.
 33. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. Phila-
delphia: Lippincott Williams & Wilkins; 2008.
 34. Yeatman S, Sennott C. The sensitivity of measures of unwanted
and unintended pregnancy using retrospective and prospec-
tive reporting: evidence from Malawi. Matern Child Hlth J.
2015;19(7):1593–600.
 35. Speizer IS, Lance P. Fertility desires, family planning use and
pregnancy experience: longitudinal examination of urban areas in 
three African countries. BMC Pregnancy Childbirth. 2015;15:294.
 36. Haberlen SA, Narasimhan M, Beres LK, Kennedy CE. Integration 
of family planning services into HIV care and treatment services:
a systematic review. Stud Fam Plann. 2017;48(2):153–77.
 37. Zash R, Makhema J, Shapiro RL. Neural-tube defects with dolute-
gravir treatment from the time of conception. N Engl J Med.
2018;379(10):979–81.
 38. Rocca CH, Ralph LJ, Gould H, Barar R, Foster DG. Measuring
Pregnancy Preferences Prospectively: a Multidimensional Psy-
chometric Instrument. Population Association of America Annual 
Meeting. Chicago, IL, April 27–29 2017. https ://paa.confe x.com/
paa/2017/meeti ngapp .cgi/Paper /16597 . Accessed 1 Dec 2018.
 39. Mumford SL, Sapra KJ, King RB, Louis JF, Buck Louis GM.
Pregnancy intentions—a complex construct and call for new
measures. Fertil Steril. 2016;106(6):1453–62.
 40. Clouse K, Vermund SH, Maskew M, et al. Mobility and clinic
switching among postpartum women considered lost to HIV care 
in South Africa. J Acquir Immune Defic Syndr. 2017;74(4):383–9.
 41. Mugavero MJ, Westfall AO, Cole SR, et al. Beyond core indi-
cators of retention in HIV care: missed clinic visits are inde-
pendently associated with all-cause mortality. Clin Infect Dis.
2014;59(10):1471–9.
 42. Matthews LT, Beyeza-Kashesya J, Cooke I, et al. Consensus
statement: supporting safer conception and pregnancy for men
and women living with and affected by HIV. AIDS Behav.
2017;22:1713–24.
 43. Schwartz SR, West N, Phofa R, et al. Acceptability and prefer-
ences for safer conception HIV prevention strategies: a qualitative
study. Int J STD AIDS. 2016;27(11):984–92.
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
